1. Home
  2. ULH vs TBPH Comparison

ULH vs TBPH Comparison

Compare ULH & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULH
  • TBPH
  • Stock Information
  • Founded
  • ULH 1932
  • TBPH 2013
  • Country
  • ULH United States
  • TBPH United States
  • Employees
  • ULH N/A
  • TBPH N/A
  • Industry
  • ULH Trucking Freight/Courier Services
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULH Industrials
  • TBPH Health Care
  • Exchange
  • ULH Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • ULH 635.2M
  • TBPH 536.5M
  • IPO Year
  • ULH 2005
  • TBPH N/A
  • Fundamental
  • Price
  • ULH $27.40
  • TBPH $11.39
  • Analyst Decision
  • ULH Hold
  • TBPH Strong Buy
  • Analyst Count
  • ULH 1
  • TBPH 5
  • Target Price
  • ULH $29.00
  • TBPH $16.60
  • AVG Volume (30 Days)
  • ULH 52.5K
  • TBPH 224.7K
  • Earning Date
  • ULH 07-24-2025
  • TBPH 08-04-2025
  • Dividend Yield
  • ULH 1.54%
  • TBPH N/A
  • EPS Growth
  • ULH N/A
  • TBPH N/A
  • EPS
  • ULH 3.17
  • TBPH N/A
  • Revenue
  • ULH $1,736,518,000.00
  • TBPH $65,266,000.00
  • Revenue This Year
  • ULH N/A
  • TBPH $51.74
  • Revenue Next Year
  • ULH $7.88
  • TBPH N/A
  • P/E Ratio
  • ULH $8.58
  • TBPH N/A
  • Revenue Growth
  • ULH 1.16
  • TBPH 6.11
  • 52 Week Low
  • ULH $20.60
  • TBPH $7.44
  • 52 Week High
  • ULH $53.29
  • TBPH $11.82
  • Technical
  • Relative Strength Index (RSI)
  • ULH 56.21
  • TBPH 62.42
  • Support Level
  • ULH $26.50
  • TBPH $10.95
  • Resistance Level
  • ULH $27.71
  • TBPH $11.68
  • Average True Range (ATR)
  • ULH 1.19
  • TBPH 0.30
  • MACD
  • ULH 0.10
  • TBPH 0.02
  • Stochastic Oscillator
  • ULH 59.01
  • TBPH 76.71

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: